OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Current management strategies for polycythemia vera and essential thrombocythemia
Paola Guglielmelli, Alessandro M. Vannucchi
Blood Reviews (2020) Vol. 42, pp. 100714-100714
Open Access | Times Cited: 53

Showing 1-25 of 53 citing articles:

Essential thrombocythemia: 2024 update on diagnosis, risk stratification, and management
Ayalew Tefferi, Alessandro M. Vannucchi, Tiziano Barbui
American Journal of Hematology (2024) Vol. 99, Iss. 4, pp. 697-718
Open Access | Times Cited: 45

SURPASS-ET: phase III Study of Ropeginterferon Alfa-2b versus Anagrelide as Second-Line Therapy in Essential Thrombocythemia
Srđan Verstovšek, Norio Komatsu, Harinder Gill, et al.
Future Oncology (2022) Vol. 18, Iss. 27, pp. 2999-3009
Open Access | Times Cited: 31

An Approach to the Investigation of Thrombocytosis: Differentiating between Essential Thrombocythemia and Secondary Thrombocytosis
Ala Almanaseer, Benjamin Chin‐Yee, Jenny Ho, et al.
Advances in Hematology (2024) Vol. 2024, Iss. 1
Open Access | Times Cited: 8

New Perspectives on Polycythemia Vera: From Diagnosis to Therapy
Alessandra Iurlo, Daniele Cattaneo, Cristina Bucelli, et al.
International Journal of Molecular Sciences (2020) Vol. 21, Iss. 16, pp. 5805-5805
Open Access | Times Cited: 45

Absence of hydroxyurea‐induced mutational effects supports higher utilisation for the treatment of sickle cell anaemia
Russell E. Ware, Stephen D. Dertinger
British Journal of Haematology (2021) Vol. 194, Iss. 2, pp. 252-266
Open Access | Times Cited: 29

Crucial roles of red blood cells and platelets in whole blood thrombin generation
Siyu Sun, Elena Campello, Jinmi Zou, et al.
Blood Advances (2023) Vol. 7, Iss. 21, pp. 6717-6731
Open Access | Times Cited: 12

A phase II trial to assess the efficacy and safety of ropeginterferon α-2b in Chinese patients with polycythemia vera
Jie Jin, Albert Qin, Lei Zhang, et al.
Future Oncology (2023) Vol. 19, Iss. 11, pp. 753-761
Open Access | Times Cited: 11

Erythrocytosis: Diagnosis and investigation
Iman Al Noumani, Claire Harrison, Mary Frances McMullin
International Journal of Laboratory Hematology (2024) Vol. 46, Iss. S1, pp. 55-62
Open Access | Times Cited: 4

PD‐L1 overexpression correlates with JAK2‐V617F mutational burden and is associated with 9p uniparental disomy in myeloproliferative neoplasms
Jelena D. Milosevic Feenstra, Roland Jäger, Fiorella Schischlik, et al.
American Journal of Hematology (2022) Vol. 97, Iss. 4, pp. 390-400
Open Access | Times Cited: 18

Budd-Chiari Syndrome as an Initial Presentation of Essential Thrombocythemia
Ana Santos e Silva, Rodrigo Morgado, Monique de Oliveira e Silva, et al.
Cureus (2025)
Open Access

Role of necroptosis and immune infiltration in essential thrombocytosis
Guangming Li, Ying Guo, Yuanyuan Zhang
Hereditas (2025) Vol. 162, Iss. 1
Open Access

Hämatologische Neoplasien und solide Tumore
Wolfgang Ludwig, Arnold Ganser, Georg Maschmeyer
Springer eBooks (2025), pp. 79-161
Closed Access

The PP2A subunit PR130 is a key regulator of cell development and oncogenic transformation
Melanie Dzulko, Miriam Pons, Andreas Henke, et al.
Biochimica et Biophysica Acta (BBA) - Reviews on Cancer (2020) Vol. 1874, Iss. 2, pp. 188453-188453
Closed Access | Times Cited: 25

Impact of CALR and JAK2V617F Mutations on Clinical Course and Disease Outcomes in Essential Thrombocythemia: A Multicenter Retrospective Study in Turkish Patients
Zehra Narlı Özdemir, Yıldız İpek, Püsem Patır, et al.
Turkish Journal of Hematology (2024), pp. 26-36
Open Access | Times Cited: 3

Ethnic sensitivity analyses of pharmacokinetics, efficacy and safety in polycythemia vera treatment with ropeginterferon alfa-2b
Albert Qin, Daoxiang Wu, Jason Liao, et al.
Frontiers in Pharmacology (2024) Vol. 15
Open Access | Times Cited: 3

DARS expression in BCR/ABL1-negative myeloproliferative neoplasms and its association with the immune microenvironment
Hao Xiong, Minjing Liao, Huitao Zhang, et al.
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 2

Impact of Hydroxyurea to Treat Haematological Disorders on Male Fertility: Two Case Reports and a Systematic Review
Simone Cilio, Giuseppe Fallara, Maria Teresa Lupo Stanghellini, et al.
The World Journal of Men s Health (2023) Vol. 42, Iss. 3, pp. 531-531
Open Access | Times Cited: 4

Liver and spleen shear-wave elastography in the diagnosis and severity staging of myeloproliferative diseases and myelofibrosis
Vito Sansone, Giuseppe Auteri, Francesco Tovoli, et al.
Journal of Ultrasound (2024) Vol. 27, Iss. 3, pp. 715-722
Closed Access | Times Cited: 1

Oncogenic Kinase Cascades Induce Molecular Mechanisms That Protect Leukemic Cell Models from Lethal Effects of De Novo dNTP Synthesis Inhibition
Miriam Pons, Yanira Zeyn, Stella Zahn, et al.
Cancers (2021) Vol. 13, Iss. 14, pp. 3464-3464
Open Access | Times Cited: 7

Differential diagnosis of leukocytosis and leukopenia
Tomáš Arpáš, Michael Doubek
Vnitřní lékařství (2022) Vol. 68, Iss. 7, pp. E28-E35
Open Access | Times Cited: 4

Correlation between IPSET-t risk at diagnosis and subsequent hemorrhage in patients with essential thrombocythemia; a single institution experience
Luca Tosoni, Matteo Liberi, Gianluca Morelli, et al.
Annals of Hematology (2023) Vol. 103, Iss. 2, pp. 443-448
Closed Access | Times Cited: 2

Onkologika
Wolfgang Ludwig, Ulrich Schwabe
Springer eBooks (2020), pp. 671-732
Closed Access | Times Cited: 3

Page 1 - Next Page

Scroll to top